Clinical trial
Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With…
NCT00046137 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00046137 |
|---|---|
| Title | Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis, Postmenopausal |
| Intervention type | Drug |
| Interventions | teriparatide, raloxifene, placebo |
| First posted | Sep 23, 2002 |
| Last update posted | Jul 20, 2006 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: